Sex differences in opioid and psychostimulant craving and relapse: a critical review

C Nicolas, NE Zlebnik, M Farokhnia, L Leggio… - Pharmacological …, 2022 - ASPET
A widely held dogma in the preclinical addiction field is that females are more vulnerable
than males to drug craving and relapse. Here, we first review clinical studies on sex …

[PDF][PDF] Sex differences in opioid and psychostimulant craving and relapse: a critical review

C Nicolas, NE Zlebnik, M Farokhnia, L Leggio… - scholar.archive.org
A widely held dogma in the preclinical addiction field is that females are more vulnerable
than males to drug craving and relapse. Here, we first review clinical studies on sex …

Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical ReviewS

C Nicolas, NE Zlbnik, M Farokhnia, L Lggio… - Pharmacological …, 2022 - hal.science
A widely held dogma in the preclinical addiction field is that females are more vulnerable
than males to drug craving and relapse. Here, we first review clinical studies on sex …

Sex differences in opioid and psychostimulant craving and relapse: a critical review

C Nicolas, NE Zlebnik, M Farokhnia, L Leggio… - medRxiv, 2021 - medrxiv.org
A widely held dogma in the preclinical addiction field is that females are more vulnerable
than males to drug craving and relapse. Here, we first review clinical studies on sex …

Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review.

C Nicolas, NE Zlebnik, M Farokhnia… - Pharmacological …, 2022 - europepmc.org
A widely held dogma in the preclinical addiction field is that females are more vulnerable
than males to drug craving and relapse. Here, we first review clinical studies on sex …

Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review

C Nicolas, NE Zlebnik, M Farokhnia, L Leggio… - Pharmacological …, 2022 - ASPET
A widely held dogma in the preclinical addiction field is that females are more vulnerable
than males to drug craving and relapse. Here, we first review clinical studies on sex …

Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review

C Nicolas, NE Zlebnik, M Farokhnia… - Pharmacological …, 2022 - pubmed.ncbi.nlm.nih.gov
A widely held dogma in the preclinical addiction field is that females are more vulnerable
than males to drug craving and relapse. Here, we first review clinical studies on sex …

Sex differences in opioid and psychostimulant craving and relapse: a critical review

C Nicolas, NE Zlebnik, M Farokhnia, L Leggio… - 2021 - europepmc.org
A widely held dogma in the preclinical addiction field is that females are more vulnerable
than males to drug craving and relapse. Here, we first review clinical studies on sex …